Atlas Capital Advisors LLC Sells 537 Shares of Sanofi (NASDAQ:SNY)

Atlas Capital Advisors LLC lessened its stake in shares of Sanofi (NASDAQ:SNY) by 23.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,769 shares of the company’s stock after selling 537 shares during the quarter. Atlas Capital Advisors LLC’s holdings in Sanofi were worth $86,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in SNY. Northern Trust Corp boosted its position in shares of Sanofi by 4.4% during the 3rd quarter. Northern Trust Corp now owns 1,415,128 shares of the company’s stock worth $75,907,000 after purchasing an additional 60,039 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Sanofi during the 3rd quarter worth about $1,860,000. O Shaughnessy Asset Management LLC raised its holdings in shares of Sanofi by 14.0% in the 3rd quarter. O Shaughnessy Asset Management LLC now owns 90,721 shares of the company’s stock worth $4,866,000 after acquiring an additional 11,167 shares during the last quarter. Qube Research & Technologies Ltd acquired a new stake in shares of Sanofi in the 3rd quarter worth about $3,945,000. Finally, Toronto Dominion Bank raised its holdings in shares of Sanofi by 175.4% in the 3rd quarter. Toronto Dominion Bank now owns 2,294 shares of the company’s stock worth $123,000 after acquiring an additional 1,461 shares during the last quarter. Institutional investors own 10.04% of the company’s stock.

Sanofi Trading Down 3.6 %

SNY opened at $48.33 on Thursday. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.27 and a quick ratio of 0.87. Sanofi has a fifty-two week low of $42.63 and a fifty-two week high of $55.72. The firm has a market capitalization of $122.41 billion, a PE ratio of 24.29, a P/E/G ratio of 1.55 and a beta of 0.60. The company’s 50-day moving average is $48.53 and its 200 day moving average is $48.55.

Sanofi (NASDAQ:SNY) last posted its earnings results on Thursday, April 25th. The company reported $0.96 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.96. Sanofi had a net margin of 10.52% and a return on equity of 26.25%. The company had revenue of $11.36 billion for the quarter, compared to analyst estimates of $11.75 billion. As a group, research analysts predict that Sanofi will post 4.13 earnings per share for the current fiscal year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.